ArticleiScience2026
Topical rewetting restores the autoimmune-damaged corneal stroma.
Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Corneal wetting is the most common treatment for dry eye disease and is generally considered palliative. Here, we challenge this view by demonstrating that rewetting the desiccated cornea of an aqueous-deficient mouse model with the simplest rewetting agent, phosphate-buffered saline (PBS), is sufficient to restore the severely disrupted collagen-rich stromal architecture required for transparency. Using transmission electron microscopy, we show substantial recovery of stromal organization, including a marked reduction in interfibrillar spacing consistent with resolution of stromal edema, following rewetting. Single-cell transcriptomic analyses further reveal that stromal keratocytes transition from an inflammatory state to a reparative-like phenotype in response to rewetting alone, demonstrating keratocyte plasticity and the potential regenerative function of rewetting. This reparative shift is mediated, in part, by dampening of IL-1β associated MAPK signaling. Together, these findings uncover an unexpected regenerative capacity of corneal rewetting and redefine its therapeutic impact in dry eye disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.